Lean, but not healthy: The 'metabolically obese, normal-weight' phenotype

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 19, Issue 6, 2016, Pages 408-417

  Ding, Cherlyn ^a   Chan, Zhiling ^a   Magkos, Faidon ^a,b  

^a AGENCY FOR SCIENCE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Body fat; Calorie restriction; Exercise; Normal weight; Obesity

Indexed keywords

ADIPOCYTOKINE;

ADIPOSE TISSUE; CARDIOMETABOLIC RISK; CARDIORESPIRATORY FITNESS; COMORBIDITY; HUMAN; INFLAMMATION; INTRAPERITONEAL FAT; LEAN BODY WEIGHT; LIPID STORAGE; MUSCLE MASS; OBESITY; PHENOTYPE; PREVALENCE; REVIEW; SKELETAL MUSCLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CLASSIFICATION; DIET; EXERCISE; FEMALE; HEART DISEASE; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

ADIPOSE TISSUE; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DIET; EXERCISE; FEMALE; HEART DISEASES; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; METABOLIC DISEASES; OBESITY; PHENOTYPE; RISK FACTORS;

EID: 84983251014     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000317     Document Type: Review

References (64)

1. World Health Organization. Fact sheet N8311. January 2015. Internet: http://www.who.int/mediacentre/factsheets/fs311/en/. [Accessed 20 April 2016]
2. Sonntag D, Ali S, De Bock F. Lifetime indirect cost of childhood overweight and obesity: a decision analytic model. Obesity 2016; 24:200-206.
3. Wee CC, Davis RB, Chiodi S, et al. Sex, race, and the adverse effects of social stigma vs. other quality of life factors among primary care patients with moderate to severe obesity. J Gen Intern Med 2015; 30:229-235.
4. Allen L, Thorpe K, Joski P. The effect of obesity and chronic conditions on Medicare spending, 1987-2011. Pharmacoeconomics 2015; 33:691-697.
5. Mozaffarian D, Benjamin EJ, Go AS, et al. Executive summary: heart disease and stroke statistics: 2016 update: a report from the American Heart Association. Circulation 2016; 133:447-454.
6. Li L, Liu DW, Yan HY, et al. Obesity is an independent risk factor for nonalcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev 2016; 17:510-519.
7. Aune D, Sen A, Norat T, et al. Body mass index, abdominal fatness, and heart failure incidence and mortality: a systematic review and dose-response metaanalysis of prospective studies. Circulation 2016; 133:639-649.
8. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384:766-781.
9. Goday A, Calvo E, Vazquez LA, et al. Prevalence and clinical characteristics of metabolically healthy obese individuals and other obese/nonobese metabolic phenotypes in a working population: results from the ICARIA study. BMC Public Health 2016; 16:248.
10. Wang B, Zhuang R, Luo X, et al. Prevalence of metabolically healthy obese and metabolically obese but normal weight in adults worldwide: a metaanalysis. Horm Metab Res 2015; 47:839-845.
11. Jung CH, Lee MJ, Kang YM, et al. The risk of incident type 2 diabetes in a Korean metabolically healthy obese population: the role of systemic inflammation. J Clin Endocrinol Metab 2015; 100:934-941.
12. Liu XM, Liu YJ, Zhan J, He QQ. Overweight, obesity and risk of all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus: a doseresponse meta-analysis of prospective cohort studies. Eur J Epidemiol 2015; 30:35-45.
13. Pandey A, Gersh BJ, McGuire DK, et al. Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF Registry. JACC: Clinical Electrophysiology 2016; 2:355-363.
14. Gupta PP, Fonarow GC, Horwich TB. Obesity and the Obesity Paradox in Heart Failure. Can J Cardiol 2015; 31:195-202.
15. Fabbrini E, Yoshino J, Yoshino M, et al. Metabolically normal obese people are protected from adverse effects following weight gain. J Clin Invest 2015; 125:787-795.
16. Brown RE, Kuk JL. Consequences of obesity and weight loss: a devil's advocate position. Obes Rev 2015; 16:77-87.
17. Karelis AD, Messier V, Brochu M, Rabasa-Lhoret R. Metabolically healthy but obese women: effect of an energy-restricted diet. Diabetologia 2008; 51:1752-1754.
18. Colangelo LA, Vu TH, Szklo M, et al. Is the association of hypertension with cardiovascular events stronger among the lean and normal weight than among the overweight and obese? The multiethnic study of atherosclerosis. Hypertension 2015; 66:286-293.
19. Carnethon MR, De Chavez PJ, Biggs ML, et al. Association of weight status with mortality in adults with incident diabetes. JAMA 2012; 308:581-590.
20. Sung K-C, Ryu S, Cheong ES, et al. All-cause and cardiovascular mortality among Koreans: effects of obesity and metabolic health. Am J Prev Med 2015; 49:62-71.
21. Fontana L, Klein S, Holloszy JO. Effects of long-term calorie restriction and endurance exercise on glucose tolerance, insulin action, and adipokine production. Age (Dordr) 2010; 32:97-108.
22. Eckel N, Mü hlenbruch K, Meidtner K, et al. Characterization of metabolically unhealthy normal-weight individuals: risk factors and their associations with type 2 diabetes. Metabolism 2015; 64:862-871.
23. Michel P, Hermans K, Amoussou-Guenou D, et al. The normal-weight type 2 diabetes phenotype revisited. Diabetes Metab Syndr 2016. [Epub ahead of print]. doi:10.1016/j.dsx.2016.01.035.
24. Ruderman NB, Schneider SH, Berchtold P. The -metabolically-obese,normal-weight individual. Am J Clin Nutr 1981; 34:1617-1621.
25. De Lorenzo A, Martinoli R, Vaia F, Di Renzo L. Normal weight obese (NWO) women: an evaluation of a candidate new syndrome. Nutr Metab Cardiovasc Dis 2006; 16:513-523.
26. Madeira FB, Silva AA, Veloso HF, et al. Normal weight obesity is associated with metabolic syndrome and insulin resistance in young adults from a middleincome country. PLoS One 2013; 8:e60673.
27. Romero-Corral A, Somers VK, Sierra-Johnson J, et al. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J 2010; 31:737-746.
28. Lee MK, Rhee EJ, Kim MC, et al. Metabolic health is more important than obesity in the development of nonalcoholic fatty liver disease: a 4-year retrospective study. Endocrinol Metab (Seoul) 2015; 30:522-530.
29. Lee SH, Han K, Yang HK, et al. A novel criterion for identifying metabolically obese but normal weight individuals using the product of triglycerides and glucose. Nutr Diabetes 2015; 5:e149.
30. Luo D, Liu F, Li X, et al. Comparison of the effect of 'metabolically healthy but obese' and 'metabolically abnormal but not obese' phenotypes on development of diabetes and cardiovascular disease in Chinese. Endocrine 2015; 49:130-138.
31. Benziger CP, Bernabé-Ortiz A, Gilman RH, et al. Metabolic abnormalities are common among South American Hispanics subjects with normal weight or excess body weight: the CRONICAS cohort study. PLoS One 2015; 10:e0138968.
32. Berg C, Strandhagen E, Mehlig K, et al. Normal weight adiposity in a Swedish population: how well is cardiovascular risk associated with excess body fat captured by BMI? Obes Sci Pract 2015; 1:50-58.
33. Badoud F, Perreault M, Zulyniak MA, Mutch DM. Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals. FASEB J 2015; 29:748-758.
34. Conus F, Rabasa-Lhoret R, Peronnet F. Characteristics of metabolically obese normal-weight (MONW) subjects. Appl Physiol Nutr Metab 2007; 32:4-12.
35. Haldar S, Chia SC, Henry CJ. Body composition in Asians and Caucasians: comparative analyses and influences on cardiometabolic outcomes. Adv Food Nutr Res 2015; 75:97-154.
36. Ablove T, Binkley N, Leadley S, et al. Body mass index continues to accuratelypredict percentage body fat as women age despite changes in muscle mass and height. Menopause 2015; 22:727-730.
37. Bohn B, Muller MJ, Simic-Schleicher G, et al. BMI or BIA: is body mass index or body fat mass a better predictor of cardiovascular risk in overweight or obese children and adolescents? A German/Austrian/Swiss Multicenter APV analysis of 3,327 children and adolescents. Obes Facts 2015; 8:156-165.
38. Owen CG, Kapetanakis VV, Rudnicka AR, et al. Body mass index in early and middle adult life: prospective associations with myocardial infarction, stroke and diabetes over a 30-year period: the British Regional Heart Study. BMJ Open 2015; 5:e008105.
39. Gallagher D, Heymsfield SB, Heo M, et al. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr 2000; 72:694-701.
40. De Lorenzo A, Bianchi A, Maroni P, et al. Adiposity rather than BMI determines metabolic risk. Int J Cardiol 2013; 166:111-117.
41. Shaikh S, Jones-Smith J, Schulze K, et al. Excessive adiposity at low BMI levels among women in rural Bangladesh. J Nutr Sci 2016; 5:e11.
42. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 1998; 47:699-713.
43. Kim TN, Park MS, Yang SJ, et al. Body size phenotypes and low muscle mass: the Korean sarcopenic obesity study (KSOS). J Clin Endocrinol Metab 2013; 98:811-817.
44. Oliveros E, Somers VK, Sochor O, et al. The concept of normal weight obesity. Prog Cardiovasc Dis 2014; 56:426-433.
45. Teixeira TF, Alves RD, Moreira AP, Peluzio Mdo C. Main characteristics of metabolically obese normal weight and metabolically healthy obese phenotypes. Nutr Rev 2015; 73:175-190.
46. Indulekha K, Surendar J, Anjana RM, et al. Metabolic obesity, adipocytokines, and inflammatory markers in Asian Indians: CURES-124. Diabetes Technol Ther 2015; 17:134-141.
47. Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest 2016; 126:12-22.
48. Gallagher D, Visser M, Sepulveda D, et al. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol 1996; 143:228-239.
49. Bradley D, Magkos F, Klein S. Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology 2012; 143:897-912.
50. St-Onge MP, Janssen I, Heymsfield SB. Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual. Diabetes Care 2004; 27:2222-2228.
51. ColditzGA,WillettWC, Rotnitzky A,Manson JE.Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122:481-486.
52. Khoo CM, Leow MK-S, Sadananthan SA, et al. Body fat partitioning does not explain the interethnic variation in insulin sensitivity among Asian ethnicity: the Singapore Adults Metabolism Study. Diabetes 2014; 63:1093-1102.
53. Khoo CM, Sairazi S, Taslim S, et al. Ethnicity modifies the relationships of insulin resistance, inflammation, and adiponectin with obesity in a multiethnic Asian population. Diabetes Care 2011; 34:1120-1126.
54. Hashemipour S, Esmailzadehha N, Mohammadzadeh M, Ziaee A. Association of meat and dairy consumption with normal weight metabolic obesity in men: the Qazvin Metabolic Diseases Study. Eat Weight Disord 2016. [Epub ahead of print]. doi:10.1007/s40519-015-0250-8.
55. Kelishadi R, Hashemipour M, Sarrafzadegan N, et al. Effects of a lifestyle modification trial among phenotypically obese metabolically normal and phenotypically obese metabolically abnormal adolescents in comparison with phenotypically normal metabolically obese adolescents. Matern Child Nutr 2010; 6:275-286.
56. Magkos F, Fraterrigo G, Yoshino J, et al. Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metab 2016; 23:591-601.
57. Anand V, Pandey A, Garg SK. Abstract 13131: impact of exercise training on cardiac structure and function in patients with type-2 diabetes or obesity: a meta-analysis of randomized control trials. Circulation 2015;132:A13131.
58. Hens W, Taeyman J, Cornelis J, et al. The effect of lifestyle interventions on excess ectopic fat deposition measured by non-invasive techniques in overweight and obese adults: a systematic review and meta-analysis. J Phys Act Health 2016; 13:671-694.
59. Konrad T, Vicini P, Kusterer K, et al. alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. Diabetes Care 1999; 22:280-287.
60. Rodríguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves the metabolic profile of metabolically obese, normal-weight individuals: a randomized double-blind placebo-controlled trial. Arch Med Res 2014; 45:388-393.
61. Salinari S, le Roux CW, Bertuzzi A, et al. Duodenal-jejunal bypass and jejunectomy improve insulin sensitivity in Goto-Kakizaki diabetic rats without changes in incretins or insulin secretion. Diabetes 2014; 63:1069-1078.
62. Grong E, Arbo IB, Thu OK, et al. The effect of duodenojejunostomy and sleeve gastrectomy on type 2 diabetes mellitus and gastrin secretion in Goto-Kakizaki rats. Surg Endosc 2015; 29:723-733.
63. Thomas EL, Parkinson JR, Frost GS, et al. The missing risk: MRI and MRS phenotyping of abdominal adiposity and ectopic fat. Obesity (Silver Spring) 2012; 20:76-87.
64. Machann J, Bongers MN, Stefan N et al. TOFI-Thin Outside, Fat Inside-identifying nonobese subjects at high risk for metabolic diseases based on MRI and MRS. ISMRM 24th Annual Meeting & Exhibition. May 7-13, 2016. Singapore. Concord, CA. ISMRM. 2016. Available at: http://cds.ismrm.org/protected/16MPresentations/abstracts/1059.html [Accessed 30 May 2016].